| Title: | APOE ε4 and Intracerebral Hemorrhage in Patients With Brain Arteriovenous Malformation |
| Journal: | JAMA Network Open |
| Published: | 5 Feb 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/38363572/ |
| DOI: | https://doi.org/10.1001/jamanetworkopen.2023.55368 |
| URL: | https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2815233/renedo_2024_oi_231626_1707425520.40351.pdf |
Publication 8783
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Importance: Intracerebral hemorrhage (ICH) is a serious complication of brain arteriovenous malformation (AVM). Apolipoprotein E (APOE) ε4 is a well-known genetic risk factor for ICH among persons without AVM, and cerebral amyloid angiopathy is a vasculopathy frequently observed in APOE ε4 carriers that may increase the risk of ICH.</p>
Objective: To assess whether APOE ε4 is associated with a higher risk of ICH in patients with a known AVM.</p>
Design, Setting, and Participants: This cross-sectional study including 412 participants was conducted in 2 stages (discovery and replication) using individual-level data from the UK Biobank (released March 2012 and last updated October 2023) and the All of Us Research Program (commenced on May 6, 2018, with its latest update provided in October 2023). The occurrence of AVM and ICH was ascertained at the time of enrollment using validated International Classification of Diseases, Ninth Revision and Tenth Revision, codes. Genotypic data on the APOE variants rs429358 and rs7412 were used to ascertain the ε status.</p>
Main Outcomes and Measures: For each study, the association between APOE ε4 variants and ICH risk was assessed among patients with a known AVM by using multivariable logistic regression.</p>
Results: The discovery phase included 253 UK Biobank participants with known AVM (mean [SD] age, 56.6 [8.0] years, 119 [47.0%] female), of whom 63 (24.9%) sustained an ICH. In the multivariable analysis of 240 participants of European ancestry, APOE ε4 was associated with a higher risk of ICH (odds ratio, 4.58; 95% CI, 2.13-10.34; P < .001). The replication phase included 159 participants with known AVM enrolled in All of Us (mean [SD] age, 57.1 [15.9] years; 106 [66.7%] female), of whom 29 (18.2%) sustained an ICH. In multivariable analysis of 101 participants of European ancestry, APOE ε4 was associated with higher risk of ICH (odds ratio, 4.52; 95% CI, 1.18-19.38; P = .03).</p>
Conclusions and Relevance: The results of this cross-sectional study of patients from the UK Biobank and All of Us suggest that information on APOE ε4 status may help identify patients with brain AVM who are at particularly high risk of ICH and that cerebral amyloid angiopathy should be evaluated as a possible mediating mechanism of the observed association.</p>
13 Authors
- Daniela Renedo
- Cyprien A. Rivier
- Andrew B. Koo
- Nanthiya Sujijantarat
- Santiago Clocchiatti-Tuozzo
- Kane Wu
- Victor M. Torres-Lopez
- Shufan Huo
- Murat Gunel
- Adam de Havenon
- Kevin N. Sheth
- Charles C. Matouk
- Guido J. Falcone
1 Application
| Application ID | Title |
|---|---|
| 58743 | Genetic and non-genetic determinants of cardiovascular disease, cerebrovascular disease, and aging. |
Enabling scientific discoveries that improve human health